Kenneth Barth

Background

About Kenneth Barth

Highly experienced and dynamic Microbiologist/Immunologist with a history of driving diverse goal-oriented research projects. Innovative critical thinker with strong written, oral, interpersonal and presentation skills, strong publication record. Significant mentoring experience has led to strong leadership and project management strengths. Enthusiastic for diverse, innovative and cutting-edge research. Spearheaded research studies examining immunomodulatory properties of human gut microbiota for drug development in treatment of ulcerative colitis. Developed, validated and completed high throughput immune screening of expansive bacterial library isolated from human stool. Developed preliminary findings into a funded National Institute of Dental and Craniofacial Research RO1 grant. Lead researcher examining the role and mechanism by which bacterial proteases affect pathogen persistence and chronic inflammation at sites local and distant from infection.*Extensive training in human microbiome, drug development, host-pathogen interactions, microbiology (aerobic and anaerobic pathogens/commensals), cell culture, innate immune signaling networks, host responses, chronic inflammation, protein biology, confocal imaging, pathway biology, assay development and murine models of disease.